Perrigo: Top 25 Undervalued Dow Jones Composite Index Stocks (PRGO)
Perrigo is now ranked among the top 25 undervalued stocks included in the Dow Jones Composite Index. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below).
Stocks in this market cap category are held primarily for capital appreciation and/or dividends. Inclusion in a major index means a company ranks among the largest in their market. This also implies stability by-way of institutional support for the stock by index funds.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| PRGO-N | Perrigo | 35.66 | 58.33 | 22.67 (63.58) | 1,063,634 | 4,799.8 | 2.9 | 0 |
| C-N | Citigroup | 41.67 | 91.6 | 49.93 (119.83) | 19,188,231 | 81,594 | 4.9 | 5.2 |
| VTRS-Q | Viatris | 8.52 | 13.5 | 4.98 (58.45) | 10,494,954 | 10,369.7 | 5.5 | 13.5 |
| GPN-N | Global Payments | 108.05 | 194.26 | 86.21 (79.79) | 2,564,769 | 30,057.5 | 0.9 | 347.3 |
| WY-N | Weyerhaeuser | 28.56 | 66.73 | 38.17 (133.66) | 4,735,152 | 21,293.801 | 2.5 | 8.7 |
| PVH-N | PVH | 44.8 | 99.92 | 55.12 (123.03) | 2,222,869 | 3,001.6 | 0.3 | 3.4 |
| PENN-Q | PENN Entertainment | 27.51 | 49.55 | 22.04 (80.12) | 5,358,159 | 4,957.3 | 0 | 22.7 |
| MRNA-Q | Moderna | 118.25 | 241.09 | 122.84 (103.88) | 5,249,093 | 49,546.801 | 0 | 3.6 |
| DXC-N | DXC Technology | 24.48 | 52.21 | 27.73 (113.27) | 4,669,375 | 5,811.1 | 0 | 11.3 |
| MAS-N | Masco | 46.69 | 79.29 | 32.6 (69.83) | 2,043,115 | 10,878.8 | 2.3 | 13.1 |
| BA-N | Boeing | 121.08 | 305.46 | 184.38 (152.28) | 7,210,604 | 72,175.797 | 0 | 0 |
| DD-N | DuPont de Nemours | 50.4 | 97.93 | 47.53 (94.31) | 3,206,382 | 25,517.5 | 2.6 | 16.9 |
| SWKS-Q | Skyworks Solutions | 85.27 | 136.3 | 51.03 (59.85) | 1,961,846 | 13,771.1 | 2.7 | 10.8 |
| HPE-N | Hewlett Packard | 11.98 | 24.5 | 12.52 (104.48) | 13,226,575 | 15,849.5 | 4 | 4.3 |
| CCL-N | Carnival | 7.03 | 14.08 | 7.05 (100.35) | 59,080,012 | 8,014.2 | 0 | 0 |
| CAH-N | Cardinal Health | 66.68 | 104.47 | 37.79 (56.68) | 3,111,609 | 18,603.699 | 3 | 0 |
| CRM-N | Salesforce | 143.84 | 263.23 | 119.39 (83) | 7,331,497 | 143,983.797 | 0 | 276.6 |
| LUMN-N | Lumen Technologies | 7.28 | 12.74 | 5.46 (74.94) | 18,192,647 | 7,401 | 13.7 | 3.8 |
| UA-N | Under Armour | 5.96 | 11.67 | 5.71 (95.76) | 4,479,804 | 2,790.3 | 0 | 12.7 |
| DISH-Q | DISH Network | 13.83 | 29.19 | 15.36 (111.08) | 4,461,633 | 8,811.4 | 0 | 4.3 |
| UHS-N | Universal Health Services | 88.18 | 170.58 | 82.4 (93.45) | 713,401 | 6,563.7 | 0.9 | 9 |
| VNO-N | Vornado Realty | 23.16 | 56.04 | 32.88 (141.96) | 2,334,927 | 4,447.6 | 9.2 | 35.3 |
| UAA-N | Under Armour | 6.65 | 13.94 | 7.29 (109.68) | 7,095,582 | 3,113.3 | 0 | 14.1 |
| BAX-N | Baxter Intl | 53.86 | 85.81 | 31.95 (59.31) | 3,086,890 | 27,360.9 | 2.1 | 26.9 |
| FBHS-N | Fortune Brands Home | 53.69 | 114.22 | 60.53 (112.74) | 1,342,272 | 7,044.1 | 2 | 9.7 |
More about Perrigo
All data provided as-at market close September 29, 2022. The list is sorted by stocks with the greatest percentage difference between valuation and price. Perrigo Perrigo Co PLC is a healthcare company providing branded OTC products throughout Europe and the USA. It sells its products primarily in North America and Europe, as well as in other markets, including Australia, Israel and China. Perrigo is listed under PRGO on the New York Stock Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs. StockCalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. StockCalc's Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including: Discounted Cash Flow (DCF), Price & Other Comparables, Multiples, Adjusted Book Value (ABV) and Analyst Consensus
Artificial intelligence at Report on Business
Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
